Jacob T. Jackson

1.8k total citations
36 papers, 1.3k citations indexed

About

Jacob T. Jackson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jacob T. Jackson has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jacob T. Jackson's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (9 papers) and Immunotherapy and Immune Responses (8 papers). Jacob T. Jackson is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (9 papers) and Immunotherapy and Immune Responses (8 papers). Jacob T. Jackson collaborates with scholars based in Australia, United States and United Kingdom. Jacob T. Jackson's co-authors include Phillip K. Darcy, Mark J. Smyth, Michael H. Kershaw, Joseph A. Trapani, Stephen M. Jane, Michele W.L. Teng, Nicole M. Haynes, Stephen L. Nutt, Loretta Cerruti and Jane E. Tanner and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Jacob T. Jackson

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob T. Jackson Australia 20 722 640 389 184 139 36 1.3k
Beatriz Martín-Antonio Spain 20 664 0.9× 391 0.6× 278 0.7× 79 0.4× 266 1.9× 49 1.2k
Anna Morena D’Alise Italy 19 592 0.8× 464 0.7× 866 2.2× 349 1.9× 56 0.4× 42 1.7k
Randall Armstrong United States 18 560 0.8× 445 0.7× 349 0.9× 58 0.3× 190 1.4× 37 1.4k
Silvia Sartoris Italy 21 716 1.0× 391 0.6× 304 0.8× 111 0.6× 47 0.3× 63 1.2k
Vijaya L. Simhadri United States 12 465 0.6× 230 0.4× 699 1.8× 171 0.9× 144 1.0× 23 1.2k
Renée Lengagne France 20 482 0.7× 357 0.6× 486 1.2× 468 2.5× 80 0.6× 26 1.2k
Anatoli Malyguine United States 20 785 1.1× 455 0.7× 268 0.7× 116 0.6× 43 0.3× 36 1.2k
Ravi Hingorani United States 18 1.1k 1.5× 268 0.4× 434 1.1× 64 0.3× 84 0.6× 21 1.5k
David Darling United Kingdom 16 451 0.6× 211 0.3× 372 1.0× 168 0.9× 193 1.4× 37 898
Naveen Dakappagari United States 18 542 0.8× 292 0.5× 430 1.1× 43 0.2× 63 0.5× 32 919

Countries citing papers authored by Jacob T. Jackson

Since Specialization
Citations

This map shows the geographic impact of Jacob T. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob T. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob T. Jackson more than expected).

Fields of papers citing papers by Jacob T. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob T. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob T. Jackson. The network helps show where Jacob T. Jackson may publish in the future.

Co-authorship network of co-authors of Jacob T. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob T. Jackson. A scholar is included among the top collaborators of Jacob T. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob T. Jackson. Jacob T. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aróstegui, Juan I., Ashley P. Ng, Waruni Abeysekera, et al.. (2023). G-CSF drives autoinflammation in APLAID. Nature Immunology. 24(5). 814–826. 10 indexed citations
2.
Jackson, Jacob T., Stephen L. Nutt, & Matthew P. McCormack. (2023). The Haematopoietically-expressed homeobox transcription factor: roles in development, physiology and disease. Frontiers in Immunology. 14. 1197490–1197490. 4 indexed citations
3.
Jackson, Jacob T., et al.. (2021). The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration. Journal of Biological Chemistry. 297(2). 100905–100905. 64 indexed citations
4.
Shields, Benjamin J., Jacob T. Jackson, Raed Alserihi, et al.. (2021). T-ALL can evolve to oncogene independence. Leukemia. 35(8). 2205–2219. 4 indexed citations
5.
Fedele, Pasquale L., Yang Liao, Jianan Gong, et al.. (2020). The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival. Leukemia. 35(7). 2114–2118. 21 indexed citations
6.
Scheer, Sebastian, Jacob T. Jackson, Soroor Hediyeh-zadeh, et al.. (2020). Hhex Directly Represses BIM-Dependent Apoptosis to Promote NK Cell Development and Maintenance. Cell Reports. 33(3). 108285–108285. 8 indexed citations
7.
Shields, Benjamin J., Christopher Slape, Jacob T. Jackson, et al.. (2019). The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1. Leukemia. 33(8). 1868–1880. 12 indexed citations
8.
Shields, Benjamin J., Jacob T. Jackson, Donald Metcalf, et al.. (2016). Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a. Genes & Development. 30(1). 78–91. 22 indexed citations
9.
McCormack, Matthew P., Benjamin J. Shields, Jacob T. Jackson, et al.. (2013). Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. Blood. 122(12). 2093–2103. 47 indexed citations
10.
Jackson, Jacob T., Yifang Hu, Ruijie Liu, et al.. (2011). Id2 expression delineates differential checkpoints in the genetic program of CD8α + and CD103 + dendritic cell lineages. The EMBO Journal. 30(13). 2690–2704. 110 indexed citations
11.
Kozer, Noga, Christine Henderson, Jacob T. Jackson, et al.. (2011). Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells. Physical Biology. 8(6). 66002–66002. 22 indexed citations
12.
Pegram, Hollie J., Jacob T. Jackson, Mark J. Smyth, Michael H. Kershaw, & Phillip K. Darcy. (2008). Adoptive Transfer of Gene-Modified Primary NK Cells Can Specifically Inhibit Tumor Progression In Vivo. The Journal of Immunology. 181(5). 3449–3455. 45 indexed citations
13.
Kershaw, Michael H., Jacob T. Jackson, Nicole M. Haynes, et al.. (2004). Gene-Engineered T Cells as a Superior Adjuvant Therapy for Metastatic Cancer. The Journal of Immunology. 173(3). 2143–2150. 65 indexed citations
14.
Moeller, Maria, Nicole M. Haynes, Joseph A. Trapani, et al.. (2004). A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells. Cancer Gene Therapy. 11(5). 371–379. 50 indexed citations
15.
Clarke, Christopher J., et al.. (2004). Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2. Biochemical and Biophysical Research Communications. 326(2). 417–424. 35 indexed citations
16.
Haynes, Nicole M., Joseph A. Trapani, Michele W.L. Teng, et al.. (2003). Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation. The Journal of Immunology. 170(6). 3440–3440. 5 indexed citations
17.
Haynes, Nicole M., Joseph A. Trapani, Michele W.L. Teng, et al.. (2002). Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors. Blood. 100(9). 3155–3163. 150 indexed citations
18.
Haynes, Nicole M., Joseph A. Trapani, Michele W.L. Teng, et al.. (2002). Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation. The Journal of Immunology. 169(10). 5780–5786. 86 indexed citations
19.
Jackson, Jacob T., et al.. (2002). Blind Steganography Detection Using a Computational Immune System Approach: A Proposal. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Martín-Antonio Breakdown of academic impact, for papers by Anna Morena D’Alise Breakdown of academic impact, for papers by Randall Armstrong Breakdown of academic impact, for papers by Silvia Sartoris Breakdown of academic impact, for papers by Vijaya L. Simhadri Breakdown of academic impact, for papers by Renée Lengagne Breakdown of academic impact, for papers by Anatoli Malyguine Breakdown of academic impact, for papers by Ravi Hingorani Breakdown of academic impact, for papers by David Darling Breakdown of academic impact, for papers by Naveen Dakappagari
Rankless by CCL
2026